Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients

Constantina Chalikiopoulou, Anastasia Gerasimoula Tavianatou, Argyro Sgourou, Alexandra Kourakli, Dimitra Kelepouri, Maria Chrysanthakopoulou, Vasiliki Kaliopi Kanelaki, Evangelos Mourdoukoutas, Stavroula Siamoglou, Anne John, Argyris Symeonidis, Bassam R. Ali, Theodora Katsila, Adamantia Papachatzopoulou, George P. Patrinos

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology